Aceragen, Inc. (ACGN) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 74 transactions totaling $458.5K, demonstrating a bearish sentiment with -$381.9K in net insider flow. The most recent transaction on Aug 10, 2023 involved a sale of 3,283 shares valued at $1.7K.
No significant insider buying has been recorded for ACGN in the recent period.
No significant insider selling has been recorded for ACGN in the recent period.
Based on recent SEC filings, insider sentiment for ACGN is bearish with an Insider Alignment Score of 8/100 and a net flow of -$381.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Aceragen, Inc. (ACGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading ACGN stock, having executed 74 transactions in the past 90 days. The most active insider is Atul Chopra (Executive), who has made 66 transactions totaling $409.3K.
Get notified when executives and directors at ACGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | Milano Vincent | Executive | Sale | 3,283 | $0.53 | $1.7K | |
| Aug 10, 2023 | Gowen Maxine | Executive | Sale | 51 | $0.51 | $26 | |
| Jul 13, 2023 | Foundation, L.p. Pillar Partners | Executive | Sale | 2,213 | $1.54 | $3.4K | |
| Jul 12, 2023 | Foundation, L.p. Pillar Partners | Executive | Sale | 3,605 | $1.58 | $5.7K | |
| May 17, 2023 | Corp Pillar Invest | Executive | Purchase | 26,965 | $1.42 | $38.3K | |
| May 17, 2023 | Chopra Atul | Executive | Sale | 601 | $1.35 | $811 | |
| May 17, 2023 | Chopra Atul | Executive | Sale | 6,181 | $1.34 | $8.3K | |
| May 17, 2023 | Chopra Atul | Executive | Sale | 15,172 | $1.33 | $20.2K | |
| May 17, 2023 | Chopra Atul | Executive | Sale | 1,049 | $1.32 | $1.4K | |
| May 17, 2023 | Chopra Atul | Executive | Sale | 257 | $1.31 | $337 | |
| May 17, 2023 | Chopra Atul | Executive | Sale | 1,540 | $1.37 | $2.1K | |
| May 16, 2023 | Chopra Atul | Executive | Sale | 9,632 | $1.43 | $13.8K | |
| May 16, 2023 | Chopra Atul | Executive | Sale | 8,205 | $1.42 | $11.7K | |
| May 16, 2023 | Chopra Atul | Executive | Sale | 10,863 | $1.41 | $15.3K | |
| May 16, 2023 | Chopra Atul | Executive | Sale | 3,736 | $1.40 | $5.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 70 | $420.2K | 91.6% |
Purchase(P) | 1 | $38.3K | 8.4% |
Exercise(M) | 3 | $0 | 0.0% |
Insider selling pressure at Aceragen, Inc. has increased, with 8 insiders executing 74 transactions across all time. Total sales of $420.2K significantly outpace purchases of $38.3K, resulting in a net outflow of $381.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.